Contineum Therapeutics, Inc. (CTNM)

Contineum Therapeutics Statistics

Total Valuation

CTNM has a market cap or net worth of $309.16 million. The enterprise value is $136.48 million.

Market Cap	309.16M
Enterprise Value	136.48M

Important Dates

The next estimated earnings date is Thursday, November 6, 2025, after market close.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

CTNM has 28.04 million shares outstanding. The number of shares has increased by 240.41% in one year.

Current Share Class	21.63M
Shares Outstanding	28.04M
Shares Change (YoY)	+240.41%
Shares Change (QoQ)	+0.10%
Owned by Insiders (%)	1.86%
Owned by Institutions (%)	35.24%
Float	14.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.68
P/TBV Ratio	1.79
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 24.51, with a Debt / Equity ratio of 0.03.

Current Ratio	24.51
Quick Ratio	24.33
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -29.24% and return on invested capital (ROIC) is -20.88%.

Return on Equity (ROE)	-29.24%
Return on Assets (ROA)	-20.42%
Return on Invested Capital (ROIC)	-20.88%
Return on Capital Employed (ROCE)	-37.59%
Revenue Per Employee	n/a
Profits Per Employee	-$1.39M
Employee Count	41
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -32.29% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-32.29%
50-Day Moving Average	11.14
200-Day Moving Average	7.41
Relative Strength Index (RSI)	46.28
Average Volume (20 Days)	100,404

Short Selling Information

The latest short interest is 1.20 million, so 4.28% of the outstanding shares have been sold short.

Short Interest	1.20M
Short Previous Month	880,331
Short % of Shares Out	4.28%
Short % of Float	8.02%
Short Ratio (days to cover)	5.19

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-66.03M
Pretax Income	-56.86M
Net Income	-56.86M
EBITDA	-65.74M
EBIT	-66.03M
Earnings Per Share (EPS)	-$2.20

Balance Sheet

The company has $175.48 million in cash and $5.75 million in debt, giving a net cash position of $169.73 million or $6.05 per share.

Cash & Cash Equivalents	175.48M
Total Debt	5.75M
Net Cash	169.73M
Net Cash Per Share	$6.05
Equity (Book Value)	171.39M
Book Value Per Share	6.61
Working Capital	169.63M

Cash Flow

In the last 12 months, operating cash flow was -$46.44 million and capital expenditures -$339,000, giving a free cash flow of -$46.78 million.

Operating Cash Flow	-46.44M
Capital Expenditures	-339,000
Free Cash Flow	-46.78M
FCF Per Share	-$1.67

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CTNM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-240.41%
Shareholder Yield	-240.41%
Earnings Yield	-18.57%
FCF Yield	-15.28%

Analyst Forecast

The average price target for CTNM is $22.20, which is 101.36% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$22.20
Price Target Difference	101.36%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1